Unknown

Dataset Information

0

Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells.


ABSTRACT: The development of novel T cell therapies to target leukemia has facilitated the translation of this approach for hematologic malignancies. Different methods of manufacturing leukemia-specific T cells have evolved, along with additional measures to increase the safety of this therapy. This is an overview of expanded T cell therapeutics with a focus on how the manufacturing strategies have been refined, and where the research is heading.

SUBMITTER: Cruz CR 

PROVIDER: S-EPMC5016253 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells.

Cruz Conrad R Y CR   Bollard Catherine M CM  

Current drug targets 20170101 3


The development of novel T cell therapies to target leukemia has facilitated the translation of this approach for hematologic malignancies. Different methods of manufacturing leukemia-specific T cells have evolved, along with additional measures to increase the safety of this therapy. This is an overview of expanded T cell therapeutics with a focus on how the manufacturing strategies have been refined, and where the research is heading. ...[more]

Similar Datasets

| S-EPMC4214360 | biostudies-literature
| S-EPMC2704307 | biostudies-literature
| S-EPMC7189290 | biostudies-literature
| S-EPMC9171381 | biostudies-literature
| S-EPMC2696596 | biostudies-literature
| S-EPMC7577233 | biostudies-literature
| S-EPMC8126293 | biostudies-literature
| S-EPMC6846700 | biostudies-literature
| S-EPMC10965654 | biostudies-literature